Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Acumen Pharmaceuticals, Inc. | Chief Legal Officer & Corp Sec | Common Stock | 109K | $378K | $3.47 | Jan 19, 2024 | Direct |
X4 Pharmaceuticals, Inc | Chief Legal Officer | Common Stock | 145K | $131K | $0.90 | Aug 17, 2022 | Direct |
Acumen Pharmaceuticals, Inc. | Chief Legal Officer & Corp Sec | Employee Stock Option (right to buy) | 137K | Jan 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ABOS | Acumen Pharmaceuticals, Inc. | Jan 19, 2024 | 1 | -$31K | 4 | Jan 19, 2024 | Chief Legal Officer & Corp Sec |
ABOS | Acumen Pharmaceuticals, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Chief Legal Officer & Corp Sec |
ABOS | Acumen Pharmaceuticals, Inc. | Jan 17, 2023 | 2 | $0 | 4 | Jan 18, 2023 | Chief Legal Office & Corp Sec |
ABOS | Acumen Pharmaceuticals, Inc. | Sep 6, 2022 | 1 | $0 | 4 | Sep 7, 2022 | Chief Legal Office & Corp Sec |
ABOS | Acumen Pharmaceuticals, Inc. | Sep 6, 2022 | 0 | $0 | 3 | Sep 7, 2022 | Chief Legal Office & Corp Sec |
XFOR | X4 Pharmaceuticals, Inc | Aug 17, 2022 | 1 | $0 | 4 | Aug 19, 2022 | Chief Legal Officer |
XFOR | X4 Pharmaceuticals, Inc | Jun 24, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Chief Legal Officer |
XFOR | X4 Pharmaceuticals, Inc | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Chief Legal Officer |
XFOR | X4 Pharmaceuticals, Inc | Mar 1, 2022 | 1 | $0 | 4 | Mar 1, 2022 | Chief Legal Officer |
XFOR | X4 Pharmaceuticals, Inc | Feb 11, 2022 | 1 | $0 | 4 | Feb 14, 2022 | Chief Legal Officer |
XFOR | X4 Pharmaceuticals, Inc | Aug 17, 2021 | 1 | -$42.5K | 4 | Aug 19, 2021 | General Counsel |
XFOR | X4 Pharmaceuticals, Inc | Jun 23, 2021 | 2 | -$29.2K | 4 | Jun 25, 2021 | General Counsel |
XFOR | X4 Pharmaceuticals, Inc | Jun 15, 2021 | 2 | -$32.7K | 4 | Jun 17, 2021 | General Counsel |